Sanofi (SNY)
(Delayed Data from NSDQ)
$48.60 USD
-0.94 (-1.90%)
Updated Mar 28, 2024 04:00 PM ET
After-Market: $48.58 -0.02 (-0.04%) 7:58 PM ET
4-Sell of 5 4
A Value B Growth C Momentum A VGM
Price, Consensus and EPS Surprise
SNY 48.60 -0.94(-1.90%)
Will SNY be a Portfolio Killer in March?
Zacks Investment Research is releasing its prediction for SNY based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for SNY
Regeneron (REGN) Gets FDA Nod for Praluent Label Extension
ASLAN (ASLN) Up 161% on Upbeat Initial Data From Eczema Study
SNY: What are Zacks experts saying now?
Zacks Private Portfolio Services
J&J (JNJ) Seeks Expanded Use of Tremfya for Ulcerative Colitis
Pharma Stock Roundup: FDA Priority Tag to SNY, ABBV Filings, CHMP Nod for AZN, JNJ, MRK
Denali's (DNLI) Q4 Earnings Miss, Pipeline in Focus, Stock Up
Other News for SNY
Smith & Nephew CFO designate John Rogers to start next week
How Is The Market Feeling About Sanofi?
First Week of May 17th Options Trading For Sanofi (SNY)
LONDON MARKET MIDDAY: FTSE 100 underperforms ahead of US PCE data
Japan approves AstraZeneca-Sanofi drug for prevention of RSV disease in infants